Ray Co

Ray Co Acquisitions (Net)

The Acquisitions (Net) of Ray Co (228670.KQ) as of Oct 30, 2026 is -3.15 B KRW. In the previous year, Acquisitions (Net) was 6.09 B KRW — a change of -151.73% (lower).

Acquisitions (Net)

-3.15 BKRW

YoY

-151.73%

Last updated:

Acquisitions (Net) of Ray Co is 2024 -3.15 B KRW. Acquisitions (Net) of Ray Co was 2023 6.09 B KRW. It decreases by -151.73% lower compared to the previous year.

The Ray Co Acquisitions (Net) history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Acquisitions (Net)
Date
Acquisitions (Net)
Jan 1, 2017
-206.00 M KRW
Jan 1, 2018
203.50 M KRW
Jan 1, 2019
-19.89 B KRW
Jan 1, 2020
1.73 B KRW
Jan 1, 2021
-42.69 B KRW
Jan 1, 2022
10.02 B KRW
Jan 1, 2023
6.09 B KRW
Jan 1, 2024
-3.15 B KRW
The Ray Co Acquisitions (Net) history
YEARAcquisitions (Net)YoY
-3.15 BKRW-151.73%
6.09 BKRW-39.25%
10.02 BKRW-123.47%
-42.69 BKRW-2,567.07%
1.73 BKRW-108.70%
-19.89 BKRW-9,873.91%
203.50 MKRW-198.79%
-206.00 MKRW+470.64%
-36.10 MKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ray Co Stock analysis

What does Ray Co do? Ray Co., Ltd. generates revenue through the manufacturing and sale of advanced technology medical devices, focusing on digital diagnostic systems and digital therapy solutions. The company produces dental radiography equipment such as x-ray systems and cone beam computed tomography (CBCT) systems, alongside 3D scanning, dental computer aided design (CAD), and 3D printers for prosthodontics, orthodontics, and implant surgery. Domestic and overseas markets purchase these products, with the company operating through subsidiaries to distribute its offerings globally. Digital diagnostic systems like dental radiography equipment and CBCT systems are sold to healthcare providers and dental clinics, while digital therapy solutions including 3D scanning and CAD systems target dental laboratories and surgical centers. The firm's product portfolio serves both domestic and international clients, leveraging its subsidiaries for global distribution channels. Ray Co., Ltd. emphasizes advanced technology in its medical device offerings, with digital therapy solutions such as 3D printers and CAD systems being key revenue drivers. The company's focus on dental-specific applications ensures targeted sales to specialized healthcare segments, including prosthodontics, orthodontics, and implant surgery practices. Ray Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ray Co stock

Acquisitions (Net) of Ray Co is -3.15 B KRW in 2024.

Acquisitions (Net) of Ray Co changed from 6.09 B KRW to -3.15 B KRW, representing a -151.73% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Acquisitions (Net) Ray Co since 2006 – with annual values, charts, and detailed analysis.

Net acquisitions represent the cash spent on acquiring other businesses, net of divestitures. Large acquisitions can transform a company's growth trajectory.

Acquisitions (Net)'s KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Acquisitions (Net)'s Ray Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Ray Co

All Key Metrics — Ray Co